Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart Milstein

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Genes & Development|August 17, 2006
C. elegans GLA-3 is a novel component of the MAP kinase MPK-1 signaling pathway required for germ cell survivalEkaterini A Kritikou, Stuart Milstein, Pierre-Olivier Vidalain, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2012
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporationWillemijn Hobo, Tatiana I Novobrantseva, Hanny Fredrix, et al.
Genome Research|October 19, 2004
C. elegans ORFeome version 3.1: increasing the coverage of ORFeome resources with improved gene predictionsPhilippe Lamesch, Stuart Milstein, Tong Hao, et al.
Nucleic Acids Research|February 25, 2023
Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editingJuan Felipe Diaz Quiroz, Namrata Ojha, Elnur E Shayhidin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2018
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA ConjugatesDonald J Foster, Christopher R Brown, Sarfraz Shaikh, et al.
Nature Methods|October 27, 2009
'Edgetic' perturbation of a C. elegans BCL2 orthologMatija Dreze, Benoit Charloteaux, Stuart Milstein, et al.
Molecular Therapy. Nucleic Acids|November 4, 2015
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA QuantificationAmy Chan, Abigail Liebow, Makiko Yasuda, et al.
Cell Metabolism|August 3, 2017
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench InvestigationChai-Wan Kim, Carol Addy, Jun Kusunoki, et al.
Cell Metabolism|September 7, 2017
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench InvestigationChai-Wan Kim, Carol Addy, Jun Kusunoki, et al.
Genome Research|October 6, 2009
Large-scale RACE approach for proactive experimental definition of C. elegans ORFeomeKourosh Salehi-Ashtiani, Chenwei Lin, Tong Hao, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Genes & Development|August 17, 2006
C. elegans GLA-3 is a novel component of the MAP kinase MPK-1 signaling pathway required for germ cell survivalEkaterini A Kritikou, Stuart Milstein, Pierre-Olivier Vidalain, et al.
Cancer Immunology, Immunotherapy : CII|August 21, 2012
Improving dendritic cell vaccine immunogenicity by silencing PD-1 ligands using siRNA-lipid nanoparticles combined with antigen mRNA electroporationWillemijn Hobo, Tatiana I Novobrantseva, Hanny Fredrix, et al.
Genome Research|October 19, 2004
C. elegans ORFeome version 3.1: increasing the coverage of ORFeome resources with improved gene predictionsPhilippe Lamesch, Stuart Milstein, Tong Hao, et al.
Nucleic Acids Research|February 25, 2023
Development of a selection assay for small guide RNAs that drive efficient site-directed RNA editingJuan Felipe Diaz Quiroz, Namrata Ojha, Elnur E Shayhidin, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 20, 2018
Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA ConjugatesDonald J Foster, Christopher R Brown, Sarfraz Shaikh, et al.
Nature Methods|October 27, 2009
'Edgetic' perturbation of a C. elegans BCL2 orthologMatija Dreze, Benoit Charloteaux, Stuart Milstein, et al.
Molecular Therapy. Nucleic Acids|November 4, 2015
Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA QuantificationAmy Chan, Abigail Liebow, Makiko Yasuda, et al.
Cell Metabolism|August 3, 2017
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench InvestigationChai-Wan Kim, Carol Addy, Jun Kusunoki, et al.
Cell Metabolism|September 7, 2017
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench InvestigationChai-Wan Kim, Carol Addy, Jun Kusunoki, et al.
Genome Research|October 6, 2009
Large-scale RACE approach for proactive experimental definition of C. elegans ORFeomeKourosh Salehi-Ashtiani, Chenwei Lin, Tong Hao, et al.
Pageof 5